Navigation Links
OpGen Announces $23.6 Million Series A Financing
Date:9/12/2007

level, within a single shift."

"There is a huge unmet need for systems to rapidly and accurately diagnose clinical infections and to control nosocomial infections," added Corey Mulloy of Highland. "We believe that OpGen's technology is uniquely placed to meet this need and to transform clinical microbiology."

OpGen is actively expanding both its product development and senior management team. A retained search for a new Chief Executive Officer is currently under way.

About OpGen

OpGen is commercializing a novel single molecule DNA analysis technology, "Optical Mapping", for rapid identification and analysis of microorganisms. The system can be used to obtain detailed genetic information with no requirement for prior sequence data, PCR, cloning, or probes. Applications of the new commercial systems include clinical microbial analysis, forensic microbiology and the development of novel molecular diagnostic products. For more information, please visit http://www.opgen.com or call 603-441-8100.

About CHL Medical Partners

CHL Medical Partners (http://www.chlmedical.com) is a venture capital firm founded in 1990, managing funds with combined committed capital of more than $300 million. The company invests mainly in start-up and early stage companies in the medical sector. The principals of CHL have been associated with numerous successful companies including GeneOhm Sciences, Incyte Pharmaceuticals, Alexion, Celgene, Amicus Therapeutics, Sempercare, American Renal Associates, Genomic Health, Odyssey Healthcare and Ameripath.

About Highland Capital Partners

Highland Capital Partners was founded with the mission of helping great people build great companies. Since its inception in 1988, the firm has taken a sector-focused approach to investing in exceptional healthcare, information technology, communications and consumer com
'/>"/>

SOURCE OpGen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. OpGen layoffs precede another funding round
2. OpGen recruits CEO to further gene-mapping business
3. OpGen adds Thomas Pyle and James Ogle to board of directors
4. OpGen forges agreement with Japanese importer
5. OpGen completes $5 million investment round
6. OpGen joins UW, Henry Ford Heath in Improving Brain Tumor Treatment
7. OpGen Creates Map of Worlds Most Lethal Fungus
8. OpGen Database Helps to Reduce Bioterrorist Threat
9. Speaker announces business members of IT Task Force
10. Doyle announces technology tax credits for Berbee
11. Doyle announces new energy, global warming policies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Mass. (PRWEB) May 16, 2013 Cambridge ... Summit from August 19-23, 2013 at the Renaissance Waterfront ... the Summit provide a close-up look at the current ... and ensuring bottom-line quality. Leaders in the field ... ways to produce biopharmaceuticals with greater specificity and efficiency. ...
(Date:5/16/2013)...  HealthSparq, a trusted provider of healthcare transparency ... health plans, will debut a new benchmark study ... 2013 conference on June 13.  The presentation will ... insurance companies across the country are thinking about ... for increased healthcare transparency. This ...
(Date:5/16/2013)... -- Scientists at the Center for Learning and Memory, ... California -based biopharmaceutical company Magceutics, Inc. ... reversing memory decline in mice with Alzheimer,s Disease. By ... in advanced stage AD mice. The study is the ... for advanced stage AD mice, and is also the ...
(Date:5/16/2013)... On average, developing a new drug takes ... Despite this investment, less than 10% of drugs make ... clinical trial design optimally structured to balance time, cost ... Frederic Sax, Global Head of the Center for Drug ... information and technology in upfront clinical trial planning and ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... May 18, 2012  Intellect Neurosciences, Inc. (OTCPK: ILNS) ... chairman and CEO, will be presenting at the ... (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) ... Tau Neoepitopes Offer Attractive Targets for Active and ...
... 2012   Pharmaceutical companies that are first to ... advantage in the competition for market share and brand ... Health Research Institute (HRI) at PwC US.  Physicians, health ... a drug will work and affect total medical costs.  ...
... 16, 2012  In an effort to voice concern on ... the Immune Deficiency Foundation (IDF) offered oral testimony at ... (FDA) public hearing on draft guidance of biosimilars products. ... from the biosimilars pathways in order to protect the ...
Cached Biology Technology:Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 2New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 3New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 4New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 5New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 6Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2
(Date:5/16/2013)... nanoparticles developed at MIT may someday eliminate the ... constantly monitor their blood-sugar levels and inject themselves ... sense glucose levels in the body and respond ... replacing the function of pancreatic islet cells, which ... Ultimately, this type of system could ensure that ...
(Date:5/16/2013)... players and athletes choose to wear the color red ... in Psychological Science , a journal of the ... to do with their testosterone levels. , The new ... University of Sunderland and colleagues, demonstrated that males who ... had higher testosterone levels than other males who chose ...
(Date:5/16/2013)... million years old give unprecedented insight into the ... the most species-rich groups among the modern bony ... Reichenbacher from the Division of Paleontology and Geobiology ... at Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have ... they assign to the group of bony fishes ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
... This release is available in German . ... experts Dr Thorsten Wiegand and Dr Andreas Huth and funded ... the Helmholtz Centre for Environmental Research (UFZ) in Leipzig. The ... from the ERC over the next five years to investigate ...
... BETHESDA, Md.The American Physiological Society (APS; www.the-aps.org ) announced ... Academy of Sciences* (NAS) report calling for the identification of ... random source dogs and cats for medical research. ... the United States Department of Agriculture (USDA) that applies to ...
... CLARA, Calif., Oct. 28 Synaptics Incorporated (Nasdaq: ... solutions for mobile computing, communications, and entertainment devices, today ... 0.75% Convertible Senior Subordinated Notes due 2024 (CUSIP No. ... option, pursuant to the terms of the Notes, to ...
Cached Biology News:ERC provides millions for biodiversity research 2ERC provides millions for biodiversity research 3American Physiological Society endorses report on random source dogs and cats 2American Physiological Society endorses report on random source dogs and cats 3Synaptics Announces Put Option for 0.75% Convertible Senior Subordinated Notes Due 2024 2Synaptics Announces Put Option for 0.75% Convertible Senior Subordinated Notes Due 2024 3
Liquid. 50 μg/ml in PBS, pH 7.4. PROTECT FROM LIGHT. A convenient form of propidium iodide useful for flow cytometry studies. RTECS SF7949600, CAS 25535-16-4, M.W. 668.4. ...
... Kit contains a green fluorescent-labeled inhibitor, FAM-VAD-FMK, ... valylalanylaspartic acid (VAD) fluoromethyl ketone (FMK), a ... added to a population of cells, the ... covalently binds to a reactive cysteine residue ...
Lyophilized solid. Suitable for evaluating functional activity of human complement components and for other research requiring a high level of hemolytic activity. ...
... VersArray ChipWriter Pro system, 220-240 V, uses ... proteins, oligonucleotides, carbohydrates, lipids, and other biomolecules ... applications. This system can generate high-density arrays ... slide or greater than 57,000 spots per ...
Biology Products: